{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_aflibercept",
          "name": "Aflibercept"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_tacrolimus",
          "name": "Tacrolimus"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_copanlisib",
          "name": "Copanlisib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_belimumab",
          "name": "Belimumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sunitinib",
          "name": "Sunitinib"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aflibercept",
          "type": "Drug",
          "label": "Aflibercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_copanlisib",
          "type": "Drug",
          "label": "Copanlisib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belimumab",
          "type": "Drug",
          "label": "Belimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sunitinib",
          "type": "Drug",
          "label": "Sunitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_a_h_u_s",
          "type": "Disease",
          "label": "Atypical haemolytic uraemic syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "显示针对该病症的疗效"
        },
        {
          "source": "drug_ravulizumab",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "类似药品效果一致"
        },
        {
          "source": "drug_aflibercept",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "免疫学机制相关假说"
        },
        {
          "source": "drug_corticosteroids",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "抗炎效果与症状缓解相关"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "用于治疗该病症的常规方法"
        },
        {
          "source": "drug_methotrexate",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "临床经验支持其使用"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "与病理结果相关"
        },
        {
          "source": "drug_tacrolimus",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "相关机制推测合理"
        },
        {
          "source": "drug_copanlisib",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "疗效潜力待探索"
        },
        {
          "source": "drug_rituximab",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "临床数据支持使用可能"
        },
        {
          "source": "drug_belimumab",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "与病症间接关联存在"
        },
        {
          "source": "drug_sunitinib",
          "target": "d_a_h_u_s",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "作用机制的假设"
        },
        {
          "source": "drug_eculizumab",
          "target": "drug_ravulizumab",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相似机制药物每两者的交集"
        },
        {
          "source": "drug_aflibercept",
          "target": "drug_corticosteroids",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "相似治疗机制"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "drug_methotrexate",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "多种策略结合性"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "drug_tacrolimus",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "多药物治疗概念"
        },
        {
          "source": "drug_copanlisib",
          "target": "drug_rituximab",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "相互作用潜力"
        },
        {
          "source": "drug_belimumab",
          "target": "drug_sunitinib",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能相互影响"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "drug_corticosteroids",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "显著效果关联"
        },
        {
          "source": "drug_eculizumab",
          "target": "drug_aflibercept",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "作用机制相关联"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多个药物对 Atypical haemolytic uraemic syndrome 有潜在治疗效果，形成多条支持性路径",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物的疗效基于已有的临床数据与临床试验结果"
    ],
    "uncertainties": [
      "具体机制与联合治疗效果尚需进一步研究"
    ],
    "next_focus_for_pi": [
      "评估各药物具体机制与临床相互作用的情况"
    ]
  }
}